Life sciences
Med tech strategy grounded in clinical evidence
We advise investors, device makers and their teams across devices, diagnostics, equipment and the services around them. Our team includes doctors and scientists. So we can judge clinical value as well as commercial strength.
Chosen in the clinic, funded by the payor
Med tech earns its keep in the clinic. A device wins because clinicians choose it, payors fund it and evidence supports it, and each of those can change. Regulation has tightened, hospital procurement has hardened, and digital is reshaping what a device even is.
The result is a sector where strong niches sit beside exposed ones, often within the same company. We help clients tell them apart, and back the products that will still be chosen in five years.
Our medtech leads
News
